Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiology

被引:133
作者
Kino, Tomoshige [1 ]
Su, Yan A. [2 ]
Chrousos, George P. [3 ]
机构
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Clin Res Ctr, Bethesda, MD 20892 USA
[2] GenProMarkers Inc, Rockville, MD 20850 USA
[3] Univ Athens, Dept Pediat 1, Athens 11527, Greece
基金
美国国家卫生研究院;
关键词
Cytoplasmic to nuclear translocation; Glucocorticoid receptor; Ligand-binding pocket; Microarray; Splicing isoform; Zebrafish; DOMINANT-NEGATIVE ACTIVITY; LIGAND-BINDING DOMAIN; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; SPLICE VARIANT; GENE VARIANT; DNA-BINDING; KAPPA-B; EXPRESSION; COACTIVATOR;
D O I
10.1007/s00018-009-0098-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human glucocorticoid receptor (GR) gene expresses two splicing isoforms alpha and beta through alternative use of specific exons 9 alpha and 9 beta. In contrast to the classic receptor GR alpha, which mediates most of the known actions of glucocorticoids, the functions of GR beta have been largely unexplored. Owing to newly developed methods, for example microarrays and the jellyfish fluorescence proteins, we and others have recently revealed novel functions of GR beta. Indeed, this enigmatic GR isoform influences positively and negatively the transcriptional activity of large subsets of genes, most of which are not responsive to glucocorticoids, in addition to its well-known dominant negative effect against GR alpha-mediated transcriptional activity. A recent report suggested that the "ligand-binding domain" of GR beta is active, forming a functional ligand-binding pocket associated with the synthetic compound RU 486. In this review, we discuss the functions of GR beta, its mechanisms of action, and its pathologic implications.
引用
收藏
页码:3435 / 3448
页数:14
相关论文
共 75 条
  • [1] [Anonymous], 2009, MOL ENDOCRINOL, DOI DOI 10.1210/me.2008-0283
  • [2] [Anonymous], HDB STRESS BRAIN
  • [3] Arnold Katja A, 2004, Nucl Recept, V2, P1, DOI 10.1186/1478-1336-2-1
  • [4] GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS
    BAMBERGER, CM
    BAMBERGER, AM
    DECASTRO, M
    CHROUSOS, GP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2435 - 2441
  • [5] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [6] A NOVEL THYROID-HORMONE RECEPTOR ENCODED BY A CDNA CLONE FROM A HUMAN TESTIS LIBRARY
    BENBROOK, D
    PFAHL, M
    [J]. SCIENCE, 1987, 238 (4828) : 788 - 791
  • [7] Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition
    Bledsoe, RK
    Montana, VG
    Stanley, TB
    Delves, CJ
    Apolito, CJ
    McKee, DD
    Consler, TG
    Parks, DJ
    Stewart, EL
    Willson, TM
    Lambert, MH
    Moore, JT
    Pearce, KH
    Xu, HE
    [J]. CELL, 2002, 110 (01) : 93 - 105
  • [8] Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids
    Breslin, MB
    Geng, CD
    Vedeckis, WV
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (08) : 1381 - 1395
  • [9] The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes
    Charmandari, E
    Chrousos, GP
    Ichijo, T
    Bhattacharyya, N
    Vottero, A
    Souvatzoglou, E
    Kino, T
    [J]. MOLECULAR ENDOCRINOLOGY, 2005, 19 (01) : 52 - 64
  • [10] Chrousos G P., 2001, Endocrinology Metabolism, P609